An abundance of p53 null mutations in ovarian carcinoma

Oncogene

Volumn 13, Issue 1, 1996, Pages 117-123

  Skilling, Jeffrey S ^a   Sood, Anil ^a   Niemann, Ted ^a   Lager, Donna J ^a   Buller, Richard E ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Deletions; Insertions; Ovarian cancer; p53 gene

Indexed keywords

PROTEIN P53;

ARTICLE; DNA REPLICATION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; OPEN READING FRAME; OVARY CANCER; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; DNA REPLICATION; DNA, NEOPLASM; FEMALE; GENES, P53; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; OPEN READING FRAMES; OVARIAN NEOPLASMS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SENSITIVITY AND SPECIFICITY; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029950851     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Buller RE, Anderson B, Connor JP and Robinson R. (1993). Gynecol. Oncol., 51, 160-166.
2. Buller RE, Skilling JS, Kaliszewski S, Niemann T and Anderson B. (1995). Gynecol. Oncol., 58, 368-374.
3. Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B and Friend SH. (1990). Mol. Cell. Biol., 10, 5772-5781.
4. Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R and Prives C. (1992). Nature, 358, 83-86.
5. Fields S and Jang SK. (1990). Science, 249, 1046-1049.
6. Fritsche M, Haessler C and Brandner G. (1993). Oncogene, 8, 307-318.
7. Fujita M, Enomoto T, Inoue M, Tanizawa O, Ozaki M, Rice JM and Nomura T. (1994). Jpn. J. Cancer Res., 85, 1247-1256.
8. Greenblatt MS, Bennett WP, Hollstein M and Harris C. (1994). Cancer Res., 54, 4855-4878.
9. Hartmann A, Blaszyk H, McGovern RM, Schroeder JJ, Cunningham J, DeVries EMG, Kovach JS and Sommer SS. (1995). Oncogene 10, 681-688.
10. Heller MJ, Burgart LJ, TenEyck CJ, Anderson ME, Greiner TC and Robinson RA. (1991). BioTechniques, 11, 372-377.
11. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC. (1994). Nucleic Acids Res., 22, 3551-3555.
12. Iggo R, Gatter K, Bartek J, Lane D and Harris AL. (1990). Lancet, 335, 675-679.
13. Inoue M, Fujita M, Enomoto T, Morimoto H, Monden T, Shimano T and Tanizawa O. (1994). Am. J. Clin. Pathol., 102, 665-670.
14. Jego N, Thomas G and Hamelin R. (1993). Oncogene, 8, 209-213.
15. Kappes S, Milde-Langosch K, Kressin P, Passlack B, Dockhorn-Dworniczak B, Rohlke P and Loning T. (1995). Int. J. Cancer, 64, 52-59.
16. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
17. Kihana T, Tsuda H, Teshima S, Okada S, Matsuura S and Hirohashi S. (1992). Jpn. J. Cancer Res., 83, 978-984.
18. Kim JW, Cho YH, Kwon DJ, Kim TE, Park TC, Lee JM and Namkoong SE. (1995). Gynecol. Oncol., 57, 199-204.
19. Klemi PJ, Pylkkanen L, Killholma P, Kurvinen K and Joensuu H. (1995). Cancer, 76, 1201-1208.
20. Kohler MF, Kerns B-JM, Humphrey PA, Marks JR, Bast RC and Berchuck A. (1993a). Obstet. Gynecol., 81, 643-650.
21. Kohler MF, Marks JR, Wiseman RW, Jacobs IJ, Davidoff AM, Clarke-Pearson DL, Soper JT, Bast RC and Berchuck A. (1993b). J. Natl. Cancer Inst., 85, 1513-1519.
22. Krawczak M and Cooper DN. (1991). Hum. Genet., 86, 425-441.
23. Kunkel TA. (1990). Biochemistry, 29, 8003-8011.
24. Kupryjanczyk J, Thor AD, Beauchamp R, Merritt V, Edgerton SM, Bell DA and Yandell DW. (1993). Proc. Natl. Acad. Sci. USA, 90, 4961-4965.
25. Kupryjanczyk J, Bell DA, Dimeo D, Beauchamp R, Thor AD and Yandell DW. (1995). Hum. Pathol., 26, 387-392.
26. Levine AJ, Momand J and Finlay CA. (1991). Nature, 351, 453-456.
27. Levine A, Perry ME, Chang A, Silver A, Dittmer D, Wu M and Welsh D. (1994). Br. J. Cancer, 69, 409-416.
28. Loeb LA. (1994). Cancer Res., 54, 5059-5063.
29. Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RC Jr and Berchuck A. (1991). Cancer Res., 51, 2979-2984.
30. Mazars R, Pujol P, Maudelonde T, Jeanteur P and Theillet C. (1991). Oncogene, 6, 1685-1690.
31. McManus DT, Yap EPH, Maxwell P, Russell SEH, Toner PG and McGee JO'D. (1994). J. Path., 174, 159-168.
32. Milner BJ, Allan LA, Eccles DM, Kitchener HC, Leonard RCF, Kelly KF, Parkin DE and Haites NE. (1993). Cancer Res., 53, 2128-2132.
33. Modrich P. (1994). Science, 266, 1959-1960.
34. Mok CH, Tsao SW, Knapp RC, Fishbaugh PM and Lau CC. (1992). Cancer Res., 52, 5119-5122.
35. Naito M, Satake M, Sakai E, Hirano Y, Tsuchida N, Kanzaki H, Ito Y and Mori T. (1992). Jpn. J. Cancer Res., 83, 1030-1036.
36. Niwa K, Itoh M, Murase T, Morishita S, Itoh N, Mori H and Tamaya T. (1994). Br. J. Cancer, 70, 1191-1197.
37. Okamoto A, Sameshima Y, Yokoyama S, Terashima Y, Sugimura T, Terada M and Yokota J. (1991). Cancer Res., 51, 5171-5176.
38. Orita M, Iwahana H, Kanazawa H, Hayashi K and Sekiya T. (1989). Proc. Natl. Acad. Sci. USA, 86, 2766-2770.
39. Runnebaum IB, Tong XW, Morbus V, Heilmann V, Kieback DG and Kreienberg R. (1994). Hum. Genet., 93, 620-624.
40. Saitoh S, Cunningham J, DeVries EM, McGovern RM. Schroeder JJ, Hartman A, Blaszyk H, Wolf LE, Schaid D, Sommer SS and Kovack JS. (1994). Oncogens, 9, 2869-2875.
41. Sambrook J, Fritsch EF and Maniates T. (1989). A laboratory manual. Cold Spring Harbor Laboratory Press: New York, pp. 9.16-9.19 and Appendix E.6.
42. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M, Brody L, Friedman L, Ostermeyer E, Szabo C, King M-C, Jhanwar S, Offit K, Norton L, Gilewski T, Lubin M, Osborne M, Black D, Boyd M, Steel M, Ingles S, Haile R, Lindblom A, Olsson H, Borg A, Bishop DT, Solomon E, Radice P, Spatti G, Gayther S, Ponder B, Warren W, Stratton M, Liu Q, Fujimura F, Lewis C, Skolnick MH and Goldgar DE. (1995). JAMA, 273, 535-541.
43. Sheridan E, Hancock BW and Goyns MH. (1993). Cancer Let., 68, 83-89.
44. Sheridan E, Silcocks P, Smith J, Hancock BW and Goyns MH. (1994). Eur. J. Cancer, 30A, 1701-1704.
45. Shiao Y-H, Chen VW, Scheer WD, Wu XC and Correa P. (1995). Cancer Res., 55, 1485-1490.
46. Sjögren S, Inganäs M, Norberg T, Lindgren A, Nordgren H, Holmberg L and Bergh J. (1996). J. Natl. Cancer Inst., 88, 173-182.
47. Skilling JS, Squatrito RC, Connor JP, Niemann T and Buller RE. (1996a). Gynecol. Oncol., 60, 72-80.
48. Skilling JS, Powills K, Lager DJ, Anderson B, Sorosky J and Buller RE. (1996b). Gynecol. Oncol. 61, 180-185.
49. Streisinger G, Okada Y, Emrich J, Newton J, Tsugita A, Terzaghi E and Inouye M. (1966). Cold Spring Harbor Symp. Quant. Biol., 31, 77-84.
50. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC and Birrer MJ. (1993). Cancer Res., 53, 3103-3108.
51. Vidal-Pulg A and Moller DE. (1994). Biotechniques, 17, 490-496.
52. Zheng J, Benedict WF, Xu HJ, Hu SX, Kim TM, Velicescu M, Wan M, Cofer KF and Dubeau L. (1995). J. Natl. Cancer Inst., 87, 1146-1153.